Replies to post #759 on Matinas Biopharma Holdings Inc (MTNB)

[RealFooFighters]

You read my previous post!

- Authorized 1:2 - 1:15 RS (Jan ’21 / Expires January 26, ’22)

Could be, perhaps they shouldn't waste it, we'll know soon!

Regardless, zero change to valuation!

Conviction: Matinas check all the boxes:

- Sound Science!
- Viable Product/Platform (clinically de-risked)!
- Strong Competent Team! (No selling!)
- Financially Sound (Cash til ’24 & No debt!)
- Huge TAM’s (Realizable & Recurring)
- Broad/Long Patent/Knowledge Moat
- Reasonable Valuation (in some cases irrational :)